Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 7/2009

01-07-2009 | Educational Series

Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients

Authors: Alfredo Carrato Mena, Luis Paz-Ares Rodríguez, Álvaro Rodríguez Lescure, Ana M. Casas Fernández de Tejerina, Eduardo Díaz Rubio García, Pedro Pérez Segura, Manuel Constenla Figueiras, Rocío García Carbonero, José Gómez Codina, Ana Lluch Hernández, José Pablo Maroto Rey, Miguel Martín Jiménez, José Ignacio Mayordomo Cámara, José Andrés Moreno Nogueira, Antonio Rueda Domínguez, on behalf of the Spanish Society of Medical Oncology (SEOM)

Published in: Clinical and Translational Oncology | Issue 7/2009

Login to get access
Metadata
Title
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients
Authors
Alfredo Carrato Mena
Luis Paz-Ares Rodríguez
Álvaro Rodríguez Lescure
Ana M. Casas Fernández de Tejerina
Eduardo Díaz Rubio García
Pedro Pérez Segura
Manuel Constenla Figueiras
Rocío García Carbonero
José Gómez Codina
Ana Lluch Hernández
José Pablo Maroto Rey
Miguel Martín Jiménez
José Ignacio Mayordomo Cámara
José Andrés Moreno Nogueira
Antonio Rueda Domínguez
on behalf of the Spanish Society of Medical Oncology (SEOM)
Publication date
01-07-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 7/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0383-1

Other articles of this Issue 7/2009

Clinical and Translational Oncology 7/2009 Go to the issue

Case Reports

Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

Research Articles

Initial surgical experience in laparoscopic total mesorectal excision for middle and lower third rectal cancer: short-term results

News and Views

Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question

Educational Series

Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials

Editorial

Spanish Researchers at the Forefront of Clinical Investigation: The case of quality of life in prostate cancer

Educational Series

Wnt signalling and cancer stem cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits